Impact of Daily Cotrimoxazole on Clinical Malaria and Asymptomatic Parasitemias in HIV-Exposed, Uninfected Infants
- Davis, Nicole L.
- Barnett, Eric J.
- Miller, William C.
- Dow, Anna
- Chasela, Charles S.
- Hudgens, Michael G.
- Kayira, Dumbani
- Tegha, Gerald
- Ellington, Sascha R.
- Kourtis, Athena P.
- Van Der Horst, Charles
- Jamieson, Denise J.
- Juliano, Jonathan J.
Publication date
January 2015
DOIAbstract
Background. Cotrimoxazole preventive therapy (CPT) is recommended for all human immunodeficiency virus (HIV)–exposed infants to avoid opportunistic infections. Cotrimoxazole has antimalarial effects and appears to reduce clinical malaria infections, but the impact on asymptomatic malaria infections is unknown
.jpg%3Fwidth%3D300&w=3840&q=75)
Add to ORKG